The investigation determined that lower than expected vitros psa results were obtained from biorad qc fluid lot 85302 level 2, when compared to the customer¿s baseline mean, using a vitros psa reagent on a vitros 5600 integrated system.A definitive assignable cause for the lower than expected vitros psa results could not be determined with the information provided.However, an unknown event that affected the calibrator 2 level on the (b)(6) 2022 calibration is the most likely cause of the lower than expected vitros psa results obtained.Based on historical quality control results, a vitros psa lot 4200 performance issue is not a likely contributor to the event.Additionally, there is also no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event.However, the customer did not perform a within run precision test at the time of the event to definitively rule out an instrument issue.Email address for contact office in field above is (b)(6).
|
The investigation determined that lower than expected vitros psa results were obtained from biorad qc fluid lot 85302 level 2, when compared to the customer¿s baseline mean, using a vitros psa reagent on a vitros 5600 integrated system.Biorad immunoassay plus control level 2 results of 2.386 and 2.396 ng/ml versus an expected result of 3.22 ng/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower than expected vitros psa results were from non-patient fluid and were not reported from the laboratory.The customer did not give any indication that patient results had been affected and there is no allegation of patient harm as a result of this event.However, the investigation cannot conclude that patient results would not be affected if the event were to occur undetected.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
|